Last updated on August 2017

Chronic Refractory Cough


Brief description of study

Chronic Refractory Cough

Detailed Study Description

A double-blind, randomized, placebo-controlled study of the efficacy and safety of three doses of Orvepitant in subjects with chronic refractory cough.

Clinical Study Identifier: TX82223

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Cherish Semeski

Vital Prospects Clinical Research Institute, P.C.
Tulsa, OK USA
  Connect »